OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cell-based reporter assays for measurements of antibody-mediated cellular cytotoxicity and phagocytosis against SARS-CoV-2 spike protein
Yuting Hong, Huilin Guo, Min Wei, et al.
Journal of Virological Methods (2022) Vol. 307, pp. 114564-114564
Open Access | Times Cited: 12
Yuting Hong, Huilin Guo, Min Wei, et al.
Journal of Virological Methods (2022) Vol. 307, pp. 114564-114564
Open Access | Times Cited: 12
Showing 12 citing articles:
Protective Role of NS1-Specific Antibodies in the Immune Response to Dengue Virus Through Antibody-Dependent Cellular Cytotoxicity
Luis A. Sánchez-Vargas, Anuja Mathew, Henrik Salje, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 5, pp. 1147-1156
Closed Access | Times Cited: 2
Luis A. Sánchez-Vargas, Anuja Mathew, Henrik Salje, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 5, pp. 1147-1156
Closed Access | Times Cited: 2
FTL004, an anti-CD38 mAb with negligible RBC binding and enhanced pro-apoptotic activity, is a novel candidate for treatments of multiple myeloma and non-Hodgkin lymphoma
Guangbing Zhang, Cuiyu Guo, Yan Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Guangbing Zhang, Cuiyu Guo, Yan Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 13
SARS‐CoV‐2 infection triggers more potent antibody‐dependent cellular cytotoxicity (ADCC) responses than mRNA‐, vector‐, and inactivated virus‐based COVID‐19 vaccines
Hadeel T. Zedan, Maria K. Smatti, Duaa W. Al‐Sadeq, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Open Access | Times Cited: 1
Hadeel T. Zedan, Maria K. Smatti, Duaa W. Al‐Sadeq, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Open Access | Times Cited: 1
UV-Inactivated rVSV-M2e-Based Influenza Vaccine Protected against the H1N1 Influenza Challenge
Titus Abiola Olukitibi, Zhujun Ao, Hiva Azizi, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 5
Open Access | Times Cited: 1
Titus Abiola Olukitibi, Zhujun Ao, Hiva Azizi, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 5
Open Access | Times Cited: 1
Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemagglutinin Stem Region Protect Mice from Group 1 Influenza a Virus Infection
Daria V. Voronina, Dmitry V. Shcheblyakov, I. A. FAVORSKAYA, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2485-2485
Open Access | Times Cited: 7
Daria V. Voronina, Dmitry V. Shcheblyakov, I. A. FAVORSKAYA, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2485-2485
Open Access | Times Cited: 7
A novel monospecific tetravalent IgG1-(scFv)2 version shown enhanced neutralizing and Fc-mediated effector functions against SARS-CoV-2
Zhangzhao Gao, Jingyu Jiao, Yaqiong Zhou, et al.
3 Biotech (2023) Vol. 13, Iss. 8
Closed Access | Times Cited: 2
Zhangzhao Gao, Jingyu Jiao, Yaqiong Zhou, et al.
3 Biotech (2023) Vol. 13, Iss. 8
Closed Access | Times Cited: 2
Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant
Hui Sun, Yizhen Wang, Xiuting Chen, et al.
Journal of Virology (2023) Vol. 97, Iss. 11
Open Access | Times Cited: 2
Hui Sun, Yizhen Wang, Xiuting Chen, et al.
Journal of Virology (2023) Vol. 97, Iss. 11
Open Access | Times Cited: 2
Cancer therapy via neoepitope-specific monoclonal antibody cocktails
Colin J. Hartman, Asmaa O. Mohamed, Girja S. Shukla, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Colin J. Hartman, Asmaa O. Mohamed, Girja S. Shukla, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Unpredicted protective function of Fc-mediated inhibitory antibodies for HIV and SARS-CoV-2 vaccines
Liyun Lin, Pierre Gantner, Shuang Li, et al.
The Journal of Infectious Diseases (2024)
Open Access
Liyun Lin, Pierre Gantner, Shuang Li, et al.
The Journal of Infectious Diseases (2024)
Open Access
Navigating the Landscape of B Cell Mediated Immunity and Antibody Monitoring in SARS-CoV-2 Vaccine Efficacy: Tools, Strategies and Clinical Trial Insights
Sophie O’Reilly, Joanne Byrne, Eoin R. Feeney, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1089-1089
Open Access
Sophie O’Reilly, Joanne Byrne, Eoin R. Feeney, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1089-1089
Open Access
Nanoparticle-based multivalent human antibodies offer potent and broad neutralization against Omicron sublineages
Yizhen Wang, Feibo Song, Siling Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Yizhen Wang, Feibo Song, Siling Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Reduced neutralization and Fc effector function to Omicron subvariants in sera from SARS‐CoV‐1 survivors after two doses of CoronaVac plus one dose subunit vaccine
Danying Chen, Xinglin Li, Xiaohua Hao, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 10
Open Access
Danying Chen, Xinglin Li, Xiaohua Hao, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 10
Open Access
